A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study group.
Zohar LandauYael LebenthalKineret Mazor-AronovitchAvivit BrenerNoah LevekTalia Jacobi-PolishookTal Ben AriShirly AbiriAlon HaimJudith NirMarianna RachmielOrit Pinhas-HamielPublished in: Endocrine (2024)
. The open-source AID youth had better glycemic control but spent longer time in the hypoglycemic range. These findings must be considered when choosing the use of AHCL technologies.